| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |